Table 4.

Predictors of Cumulative Cardiovascular Disease Assessment

	Bivariate Analyses of CVDa Assessment			Multivariate Analysis of CVDa Assessment
	Estimate	95% Confidence Interval	p-value	Estimate	95% Confidence Interval	p-value
Female (compared to male)	0.04	−0.02 to 0.10	0.16	0.01	−0.05 to 0.06	0.19
Disease Population
ESRDb (reference group)	--	--	--	--	--	--
CKDc	0.03	−0.05 to 0.12	0.47	0.04	−0.04 to 0.12	0.47
TXPd	0.09	0.01 to 0.17	0.034	0.08	0.002 to 0.15	0.045
Race and Ethinicity
Non-Hispanic White (reference group)	--	--	--	--	--	--
Non-Hispanic Black	−0.02	−0.09 to 0.05	0.62	−0.03	−0.1 to 0.03	0.31
Non-Hispanic Other	−0.02	−0.15 to 0.12	0.79	−0.02	−0.1 to 0.11	0.78
Hispanic	−0.03	−0.18 to 0.12	0.66	−0.04	−0.17 to 0.09	0.53
Formal Pathway	0.21	0.13 to 0.28	<0.001	0.20	0.12 to 0.28	<0.001
Transfer 2006 or later	0.11	0.04 to 0.18	0.002	0.09	0.02 to 0.16	0.009

^aCardiovascular disease (CVD)

^bEnd-Stage Renal Disease (ESRD)

^cChronic Kidney Disease (CKD)

^dKidney Transplant (TXP)